Search Results - "Buors, Caroline"
-
1
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes
Published in Blood cancer journal (New York) (08-04-2022)Get full text
Journal Article -
2
Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases
Published in Arthritis (01-01-2010)“…CD6 is a 105–130 kDa surface glycoprotein expressed on the majority of T cells and a subset of B cells. The human cd6 gene maps to chromosome 11, and the…”
Get full text
Journal Article -
3
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
Published in Oncotarget (03-08-2018)“…The anti-CD20-specific monoclonal antibody rituximab (RTX), in combination with chemotherapy, is commonly used for primary treatment in chronic lymphocytic…”
Get full text
Journal Article -
4
Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion
Published in European journal of haematology (01-03-2016)“…The management of patients with chronic lymphocytic leukaemia (CLL) has improved with the utilisation of ofatumumab as a novel anti‐CD20 monoclonal antibody…”
Get full text
Journal Article -
5
Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome
Published in Genes chromosomes & cancer (01-05-2017)“…Philadelphia‐negative classical myeloproliferative neoplasms (MPN) are clonal diseases characterized by driver mutations of JAK2, MPL, or CALR. Additional…”
Get full text
Journal Article -
6
Incidence and Localization of Vascular Events in a Well Characterized Cohort of 477 Patients with Myeloproliferative Neoplasms
Published in Blood (06-12-2014)“…Myeloproliferative neoplasms (MPNs) are hematopoietic disorders characterized by bone marrow and blood myeloid cells proliferation. MPNs are secondary to the…”
Get full text
Journal Article -
7
Sequential Analysis By Next Generation Sequencing of 18 Genes in Polycythemia Vera and Essential Thrombocythemia Reveals a Association Between Mutational Status and Clinical Outcome after 3-Year Follow-up
Published in Blood (03-12-2015)“…Introduction Myeloproliferative neoplasms (MPN) are molecularly characterized by driver mutations of JAK2, MPL or CALR. Other somatic mutations may occur in…”
Get full text
Journal Article -
8
The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes
Published in Leukemia & lymphoma (02-11-2017)“…Many case reports have indicated the occurrence of monoclonal gammopathy of uncertain significance (MGUS) or multiple myeloma (MM) in patients with Ph-negative…”
Get full text
Journal Article -
9
Biosimilars of filgrastim in autologous stem cell transplantation: certain differences for myeloma patients only
Published in Leukemia & lymphoma (02-09-2017)Get full text
Journal Article -
10
A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia
Published in Biochemia Medica (15-02-2020)“…This is a case report of a challenging diagnosis of IgE monoclonal gammopathy of undetermined significance, which transformed into myeloma, then transformed…”
Get full text
Journal Article Web Resource -
11
Aberrant expression of CD6 on B-cell subsets from patients with Sjögren’s syndrome
Published in Journal of autoimmunity (01-12-2010)“…Abstract CD6 is one of a pair of related genes encoding CD5-associated receptors on all T cells and a subset of B cells. The current availability of “T1h”, a…”
Get full text
Journal Article -
12
Sequential Measurement Of JAK2 V617F Allele Burden In Polycythemia Vera and Essential Thrombocythemia Reveals Different Evolution Profiles: First Results Of Jaksuivi, a Multicentre Study By The French Intergroup Of Myeloproliferative Neoplasms (FIM)
Published in Blood (15-11-2013)“…The JAK2 V617F mutation is present in almost all Polycythemia Vera (PV) and in 60-70% of Essential Thrombocythemia (ET) cases. There are experimental evidences…”
Get full text
Journal Article -
13
Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases
Published in Arthritis (2011)“…CD6 is a 105–130 kDa surface glycoprotein expressed on the majority of T cells and a subset of B cells. The human cd6 gene maps to chromosome 11, and the…”
Get full text
Journal Article -
14
A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia
Published in Biochemia medica (15-02-2020)Get full text
Report